Skip to content

By playing, you agree to uListen's Terms and Privacy Policy and YouTube's Terms of Service.

Peter Attia MDPeter Attia MD

#97 – Peter Hotez, M.D., Ph.D.: COVID-19: transmissibility, vaccines, risk reduction, and treatment

In this episode, Dr. Peter Hotez M.D., Ph.D., Dean for the National School of Tropical Medicine Baylor College of Medicine, shares his expertise on viral disease and how it applies specifically to the coronavirus disease (COVID-19) and the virus that causes it (SARS-CoV-2). Dr. Hotez informs us about the current state of disease progression, which has many unknowns, but has thus far been greatly determined by the delayed response time and lack of testing. Moreover, we discuss what we can do on a country, state, community, and individual level in order to collectively slow transmission of the disease. He shares with us a potential hope in convalescent plasma therapy and underscores the need for US federal involvement – particularly in the creation of a specialty task force to address areas of concern and unknowns. Disclaimer: This is information accurate as of March 13, 2020, when it was recorded. We discuss: - The disease and the virus: transmissibility and lethality [04:30]; - Disease transmission: US playing catch-up [12:00]; - Convalescent plasma coronavirus therapy [16:00]; - Remdesivir drug treatment and vaccination challenges [19:45]; - Disease mechanism and reported pathology [27:45]; - Most concerning geographic regions in the US [39:00]; - Risk reduction [46:30]; and - More. Show notes page: https://peterattiamd.com/peterhotez/ -------- About: The Peter Attia Drive is a weekly, ultra-deep-dive podcast focusing on maximizing health, longevity, critical thinking…and a few other things. With over 30 million episodes downloaded, it features topics including fasting, ketosis, Alzheimer’s disease, cancer, mental health, and much more. Peter is a physician focusing on the applied science of longevity. His practice deals extensively with nutritional interventions, exercise physiology, sleep physiology, emotional and mental health, and pharmacology to increase lifespan (delay the onset of chronic disease), while simultaneously improving healthspan (quality of life). Learn more: https://peterattiamd.com Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter Connect with Peter on: Facebook: http://bit.ly/PeterAttiaMDFB Twitter: http://bit.ly/PeterAttiaMDTW Instagram: http://bit.ly/PeterAttiaMDIG Subscribe to The Drive: Apple Podcast: http://bit.ly/TheDriveApplePodcasts Overcast: http://bit.ly/TheDriveOvercast Spotify: http://bit.ly/TheDriveSpotify Google Podcasts: http://bit.ly/TheDriveGoogle

Peter AttiahostDr. Peter Hotezguest
Mar 14, 202057mWatch on YouTube ↗

Summaries, chapters, transcripts, and FAQs on this page are made by uListen, not YouTube.

Episode Details

EPISODE INFO

Released
March 14, 2020
Duration
57m
Channel
Peter Attia MD
Watch on YouTube
▶ Open ↗

EPISODE DESCRIPTION

In this episode, Dr. Peter Hotez M.D., Ph.D., Dean for the National School of Tropical Medicine Baylor College of Medicine, shares his expertise on viral disease and how it applies specifically to the coronavirus disease (COVID-19) and the virus that causes it (SARS-CoV-2). Dr. Hotez informs us about the current state of disease progression, which has many unknowns, but has thus far been greatly determined by the delayed response time and lack of testing. Moreover, we discuss what we can do on a country, state, community, and individual level in order to collectively slow transmission of the disease. He shares with us a potential hope in convalescent plasma therapy and underscores the need for US federal involvement – particularly in the creation of a specialty task force to address areas of concern and unknowns. Disclaimer: This is information accurate as of March 13, 2020, when it was recorded. We discuss:

  • The disease and the virus: transmissibility and lethality [04:30];
  • Disease transmission: US playing catch-up [12:00];
  • Convalescent plasma coronavirus therapy [16:00];
  • Remdesivir drug treatment and vaccination challenges [19:45];
  • Disease mechanism and reported pathology [27:45];
  • Most concerning geographic regions in the US [39:00];
  • Risk reduction [46:30]; and
  • More.

Show notes page: https://peterattiamd.com/peterhotez/ -------- About: The Peter Attia Drive is a weekly, ultra-deep-dive podcast focusing on maximizing health, longevity, critical thinking…and a few other things. With over 30 million episodes downloaded, it features topics including fasting, ketosis, Alzheimer’s disease, cancer, mental health, and much more. Peter is a physician focusing on the applied science of longevity. His practice deals extensively with nutritional interventions, exercise physiology, sleep physiology, emotional and mental health, and pharmacology to increase lifespan (delay the onset of chronic disease), while simultaneously improving healthspan (quality of life). Learn more: https://peterattiamd.com Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter Connect with Peter on: Facebook: http://bit.ly/PeterAttiaMDFB Twitter: http://bit.ly/PeterAttiaMDTW Instagram: http://bit.ly/PeterAttiaMDIG Subscribe to The Drive: Apple Podcast: http://bit.ly/TheDriveApplePodcasts Overcast: http://bit.ly/TheDriveOvercast Spotify: http://bit.ly/TheDriveSpotify Google Podcasts: http://bit.ly/TheDriveGoogle

SPEAKERS

  • Peter Attia

    host

    Physician and host of The Drive Podcast.

  • Dr. Peter Hotez

    guest

    Vaccine scientist and tropical medicine physician at Baylor College of Medicine and Texas Children’s Hospital Center for Vaccine Development.

EPISODE SUMMARY

In this episode of Peter Attia MD, featuring Peter Attia and Dr. Peter Hotez, #97 – Peter Hotez, M.D., Ph.D.: COVID-19: transmissibility, vaccines, risk reduction, and treatment explores dr. Hotez Explains COVID-19 Transmissibility, Convalescent Serum, Vaccine Hurdles, and Mid-March Risks Hotez says SARS-CoV-2 is dangerous because it is both highly transmissible and seriously fatal for certain groups, while kids and young adults can spread it without getting very sick.

RELATED EPISODES

409 ‒ Inside modern drug development: the science, economics, and regulatory hurdles

409 ‒ Inside modern drug development: the science, economics, and regulatory hurdles

#117 – Stanley Perlman, M.D., Ph.D.: Insights from a coronavirus expert on COVID-19

#117 – Stanley Perlman, M.D., Ph.D.: Insights from a coronavirus expert on COVID-19

#150-Senator Bill Frist, MD: A modern Renaissance man's journey through science, politics & business

#150-Senator Bill Frist, MD: A modern Renaissance man's journey through science, politics & business

#130 - Carol Tavris, Ph.D. & Elliot Aronson, Ph.D.: Recognizing and overcoming cognitive dissonance

#130 - Carol Tavris, Ph.D. & Elliot Aronson, Ph.D.: Recognizing and overcoming cognitive dissonance

#96–David Epstein: How range of experience leads to better performance in a highly specialized world

#96–David Epstein: How range of experience leads to better performance in a highly specialized world

#125 - John Arnold: The most prolific philanthropist you may not have heard of

#125 - John Arnold: The most prolific philanthropist you may not have heard of

Get more out of YouTube videos.

Read along on your phone, search it beside the video, or ask your favorite AI app what was said.